Marcello Dallio
Overview
Explore the profile of Marcello Dallio including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
83
Citations
1619
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Romeo M, Dallio M, Cipullo M, Coppola A, Mazzarella C, Mammone S, et al.
Nutr Rev
. 2025 Feb;
PMID: 39992295
Objectives: This review emphasizes a novel, multidisciplinary, coordinated approach in the management of chronic liver diseases (CLDs). Background: Chronic liver diseases represent a significant global health burden, marked by a...
2.
Romeo M, Dallio M, Napolitano C, Basile C, Di Nardo F, Vaia P, et al.
Diagnostics (Basel)
. 2025 Feb;
15(3).
PMID: 39941182
In recent years, novel findings have progressively and promisingly supported the potential role of Artificial intelligence (AI) in transforming the management of various neoplasms, including hepatocellular carcinoma (HCC). HCC represents...
3.
Dallio M, Romeo M, Di Nardo F, Vaia P, Napolitano C, Ventriglia L, et al.
Int J Mol Sci
. 2025 Jan;
26(2).
PMID: 39859475
Alpha-Glutathione-S-transferase (alphaGST) is a liver enzyme whose serum levels increase with the worsening of fibrosis in alcoholic and viral chronic hepatitis. Its usefulness in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)...
4.
Dallio M, Romeo M, Di Nardo F, Napolitano C, Vaia P, Iadanza G, et al.
Nutr J
. 2025 Jan;
24(1):10.
PMID: 39819605
Background: Dysgeusia is a distortion of the sense of taste whose prevalence and relationship with nutritional status in Metabolic dysfunction-associated Steatotic Liver Disease (MASLD)-related advanced chronic liver disease (ACLD) have...
5.
Romeo M, Di Nardo F, Napolitano C, Vaia P, Federico A, Dallio M
Dig Liver Dis
. 2024 Dec;
57(2):651-652.
PMID: 39617659
No abstract available.
6.
Rosato V, Nevola R, Dallio M, Di Micco P, Spinetti A, Zeneli L, et al.
J Clin Med
. 2024 Oct;
13(19).
PMID: 39407867
Direct oral anticoagulants (DOACs) are recommended for the management of thrombosis prophylaxis, especially in patients with atrial fibrillation. As substrates of cytochrome P450 (CYP) 3A4 and/or P-glycoprotein, they are implicated...
7.
Dallio M, Sangineto M, Romeo M, Cipullo M, Coppola A, Mammone S, et al.
Nutr Diabetes
. 2024 May;
14(1):33.
PMID: 38802382
Background: Unhealthy lifestyles represent a key element fueling Non-alcoholic fatty liver disease (NAFLD) onset and worsening. We aimed to evaluate the effects of forced acute lifestyle changes on NAFLD evolution....
8.
Dallio M, Romeo M, Cipullo M, Ventriglia L, Scognamiglio F, Vaia P, et al.
Antioxidants (Basel)
. 2024 Apr;
13(4).
PMID: 38671835
Biological antioxidant potential (BAP) and Reactive Oxygen Metabolites (dROMs) are two tests complementarily assessing systemic oxidative statuses (SOSs) that are never applied in chronic liver disorders (CLDs). We enrolled 41...
9.
Scarlata G, Colaci C, Scarcella M, Dallio M, Federico A, Boccuto L, et al.
Diseases
. 2024 Apr;
12(4).
PMID: 38667527
Alcoholic liver disease (ALD) is a major cause of chronic liver disease. This term covers a broad spectrum of liver lesions, from simple steatosis to alcoholic hepatitis and cirrhosis. The...
10.
Dallio M, Romeo M, Vaia P, Auletta S, Mammone S, Cipullo M, et al.
World J Gastroenterol
. 2024 Mar;
30(7):685-704.
PMID: 38515952
Background: For compensated advanced chronic liver disease (cACLD) patients, the first decompensation represents a dramatically worsening prognostic event. Based on the first decompensation event (DE), the transition to decompensated advanced...